NCT06460948View on ClinicalTrials.gov

Identifying Oxytocin Deficiency in Adults With Pituitary Disease

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 13, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Arginine Vasopressin DeficiencyOxytocin Deficiency
Interventions
DRUG

Norethindrone Acetate-Ethinyl Estradiol

Estrogen-progestin will be given to participants in both cohorts, arginine-vasopressin deficiency cohort and healthy control cohort.

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Elizabeth Austen Lawson

OTHER